Compounds > etoposide
Page last updated: 2024-08-23

etoposide and quinoxalines

etoposide has been researched along with quinoxalines in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Katib, AM; Mensah-Osman, EJ; Mohammad, RM; Osman, NI; Wu, HY1
Al-Katib, AM; Mensah-Osman, EJ; Mohammad, RM1
Busonera, B; Carta, A; Collu, G; La Colla, P; Loddo, R; Loriga, M; Paglietti, G; Piras, S1
Acharya, A; Chaudhari, U; Hengstler, JG; Hescheler, J; Nemade, H; Papadopoulos, S; Sachinidis, A1
Dong, W; Guo, Q; Liang, J; Liu, S; Liu, Y; Su, W; Wang, Y; Xu, H; Zhang, G; Zhu, J1

Other Studies

5 other study(ies) available for etoposide and quinoxalines

ArticleYear
2-[4-(7-chloro-2-quinoxalinyloxyphenoxy]-propionic acid (XK469), an inhibitor of topoisomerase (Topo) IIbeta, up-regulates Topo IIalpha and enhances Topo IIalpha-mediated cytotoxicity.
    Molecular cancer therapeutics, 2002, Volume: 1, Issue:14

    Topics: Antigens, Neoplasm; Blotting, Western; Culture Media, Serum-Free; DNA; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enzyme Inhibitors; Etoposide; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Microscopy, Confocal; Microscopy, Fluorescence; Neoplasm Transplantation; Protein Isoforms; Quinoxalines; Time Factors; Tumor Cells, Cultured; Up-Regulation; Waldenstrom Macroglobulinemia

2002
Preclinical evaluation of 2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]-propionic acid as a modulator of etoposide in human Waldenstrom's macroglobulinemia xenograft model.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Nov-15, Volume: 9, Issue:15

    Topics: Animals; Cell Division; Etoposide; Humans; Mice; Mice, SCID; Quinoxalines; Transplantation, Heterologous; Waldenstrom Macroglobulinemia

2003
Synthesis of variously substituted 3-phenoxymethyl quinoxalin-2-ones and quinoxalines capable to potentiate in vitro the antiproliferative activity of anticancer drugs in multi-drug resistant cell lines.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2006, Volume: 2, Issue:2

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Proliferation; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Etoposide; Humans; KB Cells; Neoplasms; Quinoxalines; Tumor Cells, Cultured; Vincristine

2006
Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells.
    Archives of toxicology, 2018, Volume: 92, Issue:4

    Topics: Anthracyclines; Antineoplastic Agents; Apoptosis; Benzothiazoles; Calcium Channels; Calcium-Binding Proteins; Cell Death; Cells, Cultured; Cytoskeletal Proteins; Down-Regulation; Etoposide; Gene Expression; Humans; MicroRNAs; Mitochondria, Heart; Muscle Contraction; Myocytes, Cardiac; Pluripotent Stem Cells; Quinoxalines; Spiro Compounds; Toluene; Up-Regulation

2018
Upregulation of EID3 sensitizes breast cancer cells to ionizing radiation-induced cellular senescence.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 107

    Topics: Breast Neoplasms; Carrier Proteins; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor Proteins; DNA Damage; DNA Repair; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; Humans; Imidazoles; MCF-7 Cells; Quinoxalines; Radiation-Sensitizing Agents; Radiation, Ionizing; Time Factors; Up-Regulation

2018